Bone Marrow TransplantationBone MarrowHepatic Veno-Occlusive DiseaseBone Marrow CellsTransplantation, HomologousWhole-Body IrradiationGraft vs Host DiseaseLeukemiaAnemia, AplasticHematopoietic Stem CellsTransplantation ConditioningHematopoietic Stem Cell TransplantationMice, Inbred C57BLHematologic NeoplasmsTransplantation, AutologousBone and BonesT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow DiseasesTransplantation ChimeraBone Marrow PurgingGraft SurvivalBone Marrow ExaminationTissue DonorsBone RemodelingBusulfanHematopoiesisHistocompatibility TestingBone Marrow NeoplasmsLiver TransplantationHistocompatibilityCyclophosphamideLeukemia, Myeloid, AcuteTime FactorsImmunosuppressionTransplantation, IsogeneicRadiation ChimeraTreatment OutcomeRecurrenceBone DensityPrecursor Cell Lymphoblastic Leukemia-LymphomaCombined Modality TherapyRetrospective StudiesLeukemia, MyeloidLymphoma, Non-HodgkinMyelodysplastic SyndromesRemission InductionColony-Forming Units AssayImmunosuppressive AgentsKidney TransplantationBone ResorptionLymphomaAcute DiseaseMultiple MyelomaStem Cell TransplantationCell DifferentiationLymphocyte DepletionGraft RejectionHematologic DiseasesTransplantation ImmunologySurvival AnalysisLeukocyte TransfusionChimeraGraft vs Host ReactionFlow CytometryHLA AntigensBone NeoplasmsSevere Combined ImmunodeficiencyLymphocyte TransfusionCells, CulturedAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34SpleenGranulocyte Colony-Stimulating FactorSurvival RateLeukocyte CountPancytopeniaMice, Inbred BALB CCord Blood Stem Cell TransplantationActuarial AnalysisGraft vs Tumor EffectFollow-Up StudiesBone DevelopmentHeart TransplantationCyclosporineBone DiseasesPostoperative ComplicationsGraft vs Leukemia EffectImmunophenotypingMice, KnockoutPrognosisGranulocytesNuclear FamilyCytarabineHodgkin DiseaseOpportunistic InfectionsDisease-Free SurvivalAntibodies, MonoclonalCell SeparationImmunocompromised Host